EFM
ROIV icon

E Fund Management’s Roivant Sciences ROIV Stock Holding History

E Fund Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$485K Sell
13,700
-5,468
-29% -$162K 0.01% 276
2026
Q1 		$531K Buy
+19,168
New +$492K 0.02% 281
2025
Q2 		$743K Buy
65,954
+19,626
+42% +$213K 0.04% 194
2025
Q1 		$467K Sell
46,328
-4,319
-9% -$46.7K 0.02% 234
2024
Q4 		$599K Buy
50,647
+8,535
+20% +$101K 0.03% 200
2024
Q3 		$486K Sell
42,112
-8,269
-16% -$94.1K 0.03% 199
2024
Q2 		$533K Buy
50,381
+9,805
+24% +$107K 0.03% 172
2024
Q1 		$428K Sell
40,576
-8,284
-17% -$89.3K 0.03% 191
2023
Q4 		$549K Buy
48,860
+12,569
+35% +$122K 0.03% 140
2023
Q3 		$424K Sell
36,291
-2,434
-6% -$27.5K 0.03% 157
2023
Q2 		$390K Sell
38,725
-3,621
-9% -$32.4K 0.03% 179
2023
Q1 		$313K Buy
42,346
+29,236
+223% +$241K 0.02% 217
2022
Q4 		$105K Buy
+13,110
New +$72.9K 0.01% 329

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

E Fund Management's ROIV Position: Q2 2026 in Review

E Fund Management reduced its Roivant Sciences (ROIV) stake by 29% in Q2 2026, selling an estimated $162K and leaving 13,700 shares worth $485K. The position accounts for 0.01% of the portfolio, ranked #276.

E Fund Management first reported a position in ROIV in Q4 2022 and has held it in 13 quarters since. The position peaked at $743K in Q2 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • E Fund Management held 13,700 shares of Roivant Sciences worth $485K as of Q2 2026.
  • E Fund Management sold 5,468 Roivant Sciences shares in Q2 2026, an estimated $162K.
  • Roivant Sciences made up 0.01% of E Fund Management's portfolio in Q2 2026, its #276 holding.
  • E Fund Management first reported a position in Roivant Sciences in Q4 2022 and has held it in 13 quarters since.
  • E Fund Management's Roivant Sciences position peaked at $743K in Q2 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.